Patent · US Active

Monoclonal antibodies that inhibit the wnt signaling pathway and methods of production and use thereof

US8859736B2 · kind B2 · utility

6Cited by
2References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 18, 2011
Grant dateOct 14, 2014
Priority date—
Expiry dateApr 2, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Monoclonal antibodies against LRP6 and that block the Wnt signaling pathway are disclosed. Methods of production and use thereof are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.